• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    14.21 Down 0.34(2.30%) Dec 19, 4:00PM EST
    |After Hours : 14.10 Down 0.11 (0.77%) Dec 19, 7:50PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development12,070  12,177  12,842  10,107  
    Selling General and Administrative3,694  3,589  3,393  3,388  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (15,764) (15,766) (16,235) (13,495)
    Income from Continuing Operations
    Total Other Income/Expenses Net101  117  158  153  
    Earnings Before Interest And Taxes(15,663)(15,649)(16,077)(13,342)
    Interest Expense4  8  11  8  
    Income Before Tax(15,667)(15,657)(16,088)(13,350)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(15,667)(15,657)(16,088)(13,350)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (15,667) (15,657) (16,088) (13,350)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (15,667) (15,657) (16,088) (13,350)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.